Shengjin Tu
Shengjin Tu publishes mostly in Infectious Diseases, Epidemiology and Surgery, on topics such as COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19 and Tuberculosis Research and Epidemiology.
- World rank
- #1,604,447 of 7,710,434 ranked researchers
- Rank in China
- #241,377 of 978,568
- Works
- 21
- Citations
- 35k
- Citations per work
- 1654.4
What does Shengjin Tu research?
Shengjin Tu's work is mostly in Medicine (53%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1153.4%
- Medicine1153.4%
- Everything else839.9%
- Life Sciences16.7%
- 1Infectious Diseases20% of their works
- 2Epidemiology10% of their works
- 3Surgery10% of their works
- 4Radiology, Nuclear Medicine and Imaging7% of their works
- 5Pulmonary and Respiratory Medicine7% of their works
- 6Molecular Biology7% of their works
Research topics
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Tuberculosis Research and Epidemiology
- COVID-19 and healthcare impacts
- Pharmacological Receptor Mechanisms and Effects
- Nanoplatforms for cancer theranostics
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Shengjin Tu's research?
The keywords of their largest research topics: Epidemiology, Immune Response, Pandemic, Clinical Characteristics, SARS-CoV-2, Diagnosis, Treatment and Neurologic Manifestations.
- Pneumonia
- Photothermal Therapy
- Nanoparticles
- Chaperone
- Mycobacterium tuberculosis
- COVID-19
- Neurologic Manifestations
- Diagnosis
- Clinical Characteristics
- Immune Response
- Epidemiology
- Pandemic
- SARS-CoV-2
- Treatment
- Post-acute COVID-19 Syndrome
- Cancer
- Tuberculosis
- Mycobacterium avium
- Nontuberculous Mycobacteria
- Pneumocystis
- Sigma-1 Receptor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Epidemiology154 topics
- Immune Response112 topics
- Pandemic112 topics
- Clinical Characteristics81 topic
- SARS-CoV-281 topic
- Diagnosis73 topics
- Treatment73 topics
- Neurologic Manifestations41 topic
- Post-acute COVID-19 Syndrome41 topic
- COVID-1931 topic
- Cancer31 topic
- Mycobacterium tuberculosis31 topic
- Tuberculosis31 topic
- Chaperone21 topic
- Mycobacterium avium21 topic
- Nanoparticles21 topic
- Nontuberculous Mycobacteria21 topic
- Photothermal Therapy21 topic
- Pneumocystis21 topic
- Pneumonia21 topic
- Sigma-1 Receptor21 topic
Where does Shengjin Tu work?
Shengjin Tu's main affiliation in the publication record is Jinyintan Hospital, China.
How many publications and citations does Shengjin Tu have?
OpenAlex counts 21 works and 34,743 citations for Shengjin Tu, an h-index of 10, ranking #1,604,447 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Shengjin Tu. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.